| Secondary |
| Contraception |
20.6% |
| Rheumatoid Arthritis |
17.6% |
| Bone Marrow Failure |
14.7% |
| Metrorrhagia |
8.8% |
| Narcolepsy |
8.8% |
| Depression |
5.9% |
| Nasopharyngeal Cancer |
5.9% |
| Pain |
5.9% |
| Antiemetic Supportive Care |
2.9% |
| Gaucher's Disease |
2.9% |
| Myelodysplastic Syndrome |
2.9% |
| Product Used For Unknown Indication |
2.9% |
|
| Unintended Pregnancy |
22.2% |
| Drug Exposure During Pregnancy |
16.7% |
| Wound |
16.7% |
| Pregnancy On Oral Contraceptive |
11.1% |
| Cerebrovascular Accident |
5.6% |
| Cholelithiasis |
5.6% |
| Dizziness |
5.6% |
| Peliosis Hepatis |
5.6% |
| Peripheral Embolism |
5.6% |
| Peritoneal Haemorrhage |
5.6% |
|
| Concomitant |
| Contraception |
25.7% |
| Drug Use For Unknown Indication |
9.6% |
| Product Used For Unknown Indication |
8.6% |
| Crohn's Disease |
6.4% |
| Multiple Sclerosis |
6.1% |
| Acne |
4.9% |
| Depression |
4.9% |
| Menopause |
4.9% |
| Premenstrual Syndrome |
4.2% |
| Anxiety |
3.4% |
| Dysmenorrhoea |
2.7% |
| Hypertension |
2.7% |
| Headache |
2.5% |
| Oral Contraception |
2.5% |
| Prophylaxis |
2.2% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Back Pain |
1.7% |
| Migraine |
1.7% |
| Pain |
1.7% |
| Renal Transplant |
1.7% |
|
| Unintended Pregnancy |
18.8% |
| Vomiting |
12.5% |
| Drug Exposure During Pregnancy |
7.1% |
| Pulmonary Embolism |
6.3% |
| No Adverse Event |
4.5% |
| Pain |
4.5% |
| Paraesthesia |
4.5% |
| Weight Decreased |
4.5% |
| Depression |
3.6% |
| Headache |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Tremor |
3.6% |
| Vaginal Haemorrhage |
3.6% |
| Weight Increased |
3.6% |
| Abdominal Pain |
2.7% |
| Deep Vein Thrombosis |
2.7% |
| Hypertension |
2.7% |
| Injury |
2.7% |
| Nausea |
2.7% |
| Night Sweats |
2.7% |
|
| Interacting |
| Depression |
40.0% |
| Narcolepsy |
40.0% |
| Contraception |
20.0% |
|
| Drug Interaction |
33.3% |
| Unintended Pregnancy |
33.3% |
| Vomiting |
33.3% |
|
